D

DiaMedica Therapeutics
D

DMAC

6.51000
USD
-0.10
(-1.51%)
مغلق
حجم التداول
3,364
الربح لكل سهم
-1
العائد الربحي
-
P/E
-12
حجم السوق
278,371,389
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: DiaMedica Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.